The $33 Million Silicosis Verdict: What Caesarstone's Sixth Trial Means for Countertop Workers
On October 21, 2026, a jury assessed a $33 million verdict for the family of Jose Luis Martir Navarro, a countertop fabrication worker who developed fatal artificial stone silicosis after 13 years in the trade. It was the sixth artificial stone silicosis trial in the United States, and the fifth verdict for plaintiffs.
- The verdict, in Martir Navarro v. Caesarstone Ltd and Caesarstone USA, Inc., totaled $33 million: $25 million in noneconomic damages for Martir Navarro and $8 million for his wife's loss of consortium.
- It was the sixth artificial stone silicosis trial in the United States, and the fifth verdict in favor of plaintiffs.
- The jury found both Caesarstone entities liable for product-liability design defect under the risk-benefit test, and rejected defenses based on employer responsibility, third-party conduct, and misuse.
- Fault was apportioned as 70 percent to the employer, 11 percent each to Caesarstone Ltd and Caesarstone USA, 8 percent combined to other manufacturers and distributors, and zero percent to Martir Navarro.
- Martir Navarro developed end-stage, fatal artificial stone silicosis after 13 years fabricating countertops, and was 63 after a career working with high-silica slabs.
For plain-language explainers on related legal topics, the Problem Solved channel publishes guides that help readers understand their options before they act.
What the Jury Actually Found
The verdict turns on a single legal idea: design defect under the risk-benefit test, which asks whether a product's dangers outweigh its benefits when safer designs exist. The jury found that Caesarstone's high-silica artificial stone was defective and unsafe to fabricate under real-world conditions, and that the hazards are inherent in the stone itself. It rejected the companies' affirmative defenses, including theories that blamed the employer, other parties' negligence, superseding acts, and misuse or modification of the product. The jury still assigned the shop 70 percent of the fault, but refused to let that excuse the manufacturer.
The damages split tells the human story behind the legal one. The jury assessed $25 million in noneconomic damages for Martir Navarro himself, and $8 million for his wife, Silvia Rebeca Gudiel Garcia, for loss of consortium, the legal term for the loss of companionship and support a spouse suffers when a partner is gravely injured. Those are named verdict figures for this family, not a schedule for other workers. Compensation varies widely by case, and most settlements are confidential.
Why Artificial Stone Dust Is Different
Silicosis is a lung disease caused by inhaling respirable crystalline silica, tiny particles of silica dust that scar the lungs. Artificial stone makes the problem sharper: jurors heard that at least 90 percent of the material is respirable crystalline silica, with the remaining roughly 10 percent including highly toxic dyes, resins, glues, and heavy metals that release volatile organic compounds during fabrication. Cutting, grinding, and polishing the slabs creates nano-sized, high-surface-area silica dust, particles so fine and reactive that they drive an unusually aggressive disease. The trial evidence described artificial stone silicosis as preventable, progressive, incurable, and fatal, with no known cure, and linked it to further conditions including rheumatoid arthritis and other autoimmune diseases, chronic kidney disease, and lung cancer.
Ordinary silica exposure usually takes decades to cause severe disease; artificial stone workers have developed serious disease after just a few years. Martir Navarro's 13 years fit that pattern. For the broader picture of who can file and what the claims allege, see our guide to silica dust lawsuits and engineered stone.
The Fault Split, Explained
Comparative fault is how juries divide responsibility among everyone who contributed to an injury, and this verdict's split is unusually instructive. The employer took 70 percent, a reminder that shop owners who fail to control dust bear the largest share in these cases. Caesarstone Ltd and Caesarstone USA took 11 percent each, a combined 22 percent for the manufacturer and its distributor. Other stone manufacturers and distributors took 8 percent combined. Martir Navarro himself took zero percent, meaning the jury found no fault in his own conduct. Plaintiffs did not argue that Caesarstone was solely responsible; they argued that responsibility attributable to others did not excuse Caesarstone from liability for its own contribution. The jury agreed, and that principle is the verdict's most portable lesson: a mostly-at-fault employer does not shield a manufacturer whose product was itself defective.
The 2012 Warning and the Lower-Silica Lines
The timeline the jury heard is damning in its simplicity. Caesarstone Ltd began manufacturing its high-silica artificial stone in 1987, and Caesarstone USA began distributing its products in California in 1998. In 2012, the peer-reviewed journal CHEST reported an outbreak of artificial stone silicosis among fabricators in Israel, where more than 90 percent of the stone fabricated was Caesarstone, in an article originally titled Caesarstone Silicosis: Disease Resurgence Among Artificial Stone Workers. After that publication, the companies continued manufacturing and distributing high-silica products. In 2023, Caesarstone introduced a lower-silica line containing between 11 and 40 percent crystalline silica, and in 2025 another line containing less than 1 percent. Yet the companies continue to manufacture and distribute high-silica products, and have not provided marketing or guidance directing sales representatives to promote the lower-silica products as safer alternatives, according to the trial evidence.
That sequence is why the design-defect finding stuck: a safer alternative existed, yet buyers were not steered toward it. The regulatory backdrop reinforces the point: on May 21, 2026, California regulators voted to initiate emergency rulemaking concerning artificial stone products containing more than 1 percent crystalline silica. Rulemaking is not a ban, and workers should not mistake it for one, but it signals that regulators and juries are converging on the same conclusion about this material.
Who Benefits From This — and Who Does Not
Who benefits. Countertop fabrication workers diagnosed with silicosis or related conditions after cutting, grinding, or polishing artificial stone benefit most directly, because this is now the fifth plaintiff verdict in six trials, a track record that strengthens settlement leverage across the docket. Families of workers who died from the disease benefit too, through loss-of-consortium and wrongful-death paths that this verdict illustrates. And workers in shops that still cut high-silica slabs benefit from the warning itself: the verdict puts every shop owner on notice that dust controls are not optional. The design-defect theory behind the win is explained in our guide to winning a product liability case without proving negligence.
Who does not benefit. Workers whose lung disease has no documented artificial stone exposure gain nothing; natural stone, concrete, and other silica sources raise different proof problems. Workers who fabricated only low-silica lines, or whose exposure was brief and well-controlled, will face harder causation fights. And $33 million is not a typical outcome: it reflects an end-stage, fatal disease after 13 years.
What Workers Should Document Now
If you cut artificial stone, build the record before you need it. Keep pay records and employment dates for every shop, note the slab brands you fabricated, and photograph shop conditions, ventilation, and protective equipment where you lawfully can. Get lung screening early if you have symptoms such as shortness of breath or persistent cough, and keep every pulmonary and occupational medicine report. Tell each doctor about your stone exposure specifically, because a record that says silica exposure is far stronger than one that says only construction work. Filing deadlines are set by state law and often run from diagnosis or discovery, so do not wait for symptoms to worsen before seeking a legal review.
Frequently asked questions
Who benefits most from the Caesarstone verdict?
Countertop fabrication workers diagnosed with silicosis after cutting, grinding, or polishing artificial stone, and families of workers who died from the disease, since this is the fifth plaintiff verdict in six artificial stone trials.
Who does not qualify for a claim like this?
Workers whose lung disease has no documented artificial stone exposure, those who fabricated only low-silica lines, or those whose exposure was brief and well-controlled will face harder causation fights.
How do I start an artificial stone silicosis claim?
Record every shop and employment date, the slab brands you fabricated, and shop dust controls; get lung screening and keep all pulmonary reports; tell each doctor about your stone exposure specifically; then seek a legal review promptly, since state deadlines often run from diagnosis.
Does the $33 million verdict set what my case is worth?
No. It is a named jury verdict for one family on one record, reflecting an end-stage fatal disease after 13 years. Compensation varies widely by case, and most settlements are confidential.
Is artificial stone banned now?
No. California regulators voted on May 21, 2026, to initiate emergency rulemaking for products containing more than 1 percent crystalline silica, but rulemaking is not a ban, and high-silica products remain on the market.
What if my employer was mostly at fault?
That does not end the case: in Martir Navarro, the employer took 70 percent of the fault, yet the jury still held Caesarstone liable for its own 22 percent combined share, because another party's fault does not excuse a defective product.
This article provides general information only and is not legal advice. For advice about your specific situation, consult a qualified attorney.